Daniel Walcher

1.9k total citations
44 papers, 1.5k citations indexed

About

Daniel Walcher is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Daniel Walcher has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 9 papers in Epidemiology. Recurrent topics in Daniel Walcher's work include Adipokines, Inflammation, and Metabolic Diseases (8 papers), Diabetes and associated disorders (8 papers) and Peroxisome Proliferator-Activated Receptors (8 papers). Daniel Walcher is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (8 papers), Diabetes and associated disorders (8 papers) and Peroxisome Proliferator-Activated Receptors (8 papers). Daniel Walcher collaborates with scholars based in Germany, United States and Australia. Daniel Walcher's co-authors include Nikolaus Marx, Vinzenz Hombach, Helga Bach, Wolfgang Köenig, Thomas Först, Andreas Pfützner, Ronen Durst, Thomas R. Konrad, G Lübben and Matthias Langenfeld and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.

In The Last Decade

Daniel Walcher

43 papers receiving 1.5k citations

Peers

Countries citing papers authored by Daniel Walcher

Since Specialization

Citations

This map shows the geographic impact of Daniel Walcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Walcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Walcher more than expected).

Fields of papers citing papers by Daniel Walcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Walcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Walcher. The network helps show where Daniel Walcher may publish in the future.

Co-authorship network of co-authors of Daniel Walcher

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Walcher. A scholar is included among the top collaborators of Daniel Walcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Walcher. Daniel Walcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis 2018 ·Scientific Reports ·(unknown), Johannes Brettschneider, Jochen K. Lennerz, Daniel Walcher, Lubin Fang, Angela Rosenbohm, B. Karthikeyan, (unknown), Peter Möller, Steffen Just, Michael Willem, Albert C. Ludolph, Dietmar Rudolf Thal	13
2	Percutaneous mitral valve repair with the MitraClip NT™ system in a patient presenting with prolonged cardiogenic shock 2017 ·Clinical Case Reports ·Dominik Buckert, Sinisa Markovic, Markus Kunze, Jochen Wöhrle, Wolfgang Rottbauer, Daniel Walcher	4
3	Clinical results of single and multiple bioresorbable drug-eluting scaffolds for treatment of de-novo coronary artery disease 2016 ·Coronary Artery Disease ·Sinisa Markovic, (unknown), Daniel Walcher, Peter Bernhardt, Armin Imhof, Wolfgang Rottbauer, Jochen Wöhrle	2
4	TCT-509 Clinical follow-up after implantation of bioresorbable drug-eluting scaffolds - a prospective single center experience up to 3 years 2015 ·Journal of the American College of Cardiology ·Julia Seeger, (unknown), Birgid Gonska, Daniel Walcher, Wolfgang Rottbauer, Jochen Wöhrle	2
5	C-peptide induces human renal mesangial cell proliferation in vitro, activating Src-kinase, PI-3 kinase and ERK1/2 2012 ·Molecular and Cellular Endocrinology ·(unknown), (unknown), Ronen Durst, Helga Bach, Sonja Vogt, Wolfgang Rottbauer, Daniel Walcher	4
6	CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling 2012 ·Journal of Clinical Investigation ·(unknown), Lars Bullinger, Christine Ragu, Angela Garding, Daniel Mertens, Christina Miller, (unknown), Daniel Walcher, Konstanze Döhner, Hartmut Döhner, Rainer Claus, Christoph Plass, Stephen M. Sykes, Steven Lane, Claudia Scholl, Stefan Fröhling	41
7	C‐peptide promotes lesion development in a mouse model of arteriosclerosis 2011 ·Journal of Cellular and Molecular Medicine ·(unknown), Nikolaus Marx, Galina K. Sukhova, Helga Bach, Ronen Durst, (unknown), (unknown), Vinzenz Hombach, (unknown), Daniel Walcher	20
8	Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up 2010 ·International journal of cardiac imaging ·Peter Bernhardt, (unknown), (unknown), L. Binner, Jochen Spieß, Georg Großmann, Volker Rasche, Daniel Walcher, Vinzenz Hombach	11
9	LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration 2010 ·Basic Research in Cardiology ·Daniel Walcher, (unknown), (unknown), Helga Bach, Ronen Durst, (unknown), Vinzenz Hombach, Nikolaus Marx	17
10	Glucagon-like peptide-1(1-37) inhibits chemokine-induced migration of human CD4-positive lymphocytes 2010 ·Cellular and Molecular Life Sciences ·Nikolaus Marx, Mathias Burgmaier, (unknown), (unknown), (unknown), Helga Bach, Ronen Durst, Vinzenz Hombach, Daniel Walcher	42
11	Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension 2010 ·Diabetes Research and Clinical Practice ·Ulrich Kintscher, Nikolaus Marx, Peter Martus, (unknown), (unknown), Anna Schneider, Daniel Walcher, Andreas Kümmel, (unknown), Kai Kappert, Yvonne Dörffel, Jürgen Scholze, Thomas Unger	13
12	Advanced glycation end products and C-peptide—modulators in diabetic vasculopathy and atherogenesis 2009 ·Seminars in Immunopathology ·Daniel Walcher, Nikolaus Marx	18
13	Blood oxygen level-dependent magnetic resonance imaging using T2-prepared steady-state free-precession imaging in comparison to contrast-enhanced myocardial perfusion imaging 2009 ·International Journal of Cardiology ·Peter Bernhardt, Robert Manzke, Axel Bornstedt, (unknown), Jochen Spieß, Daniel Walcher, Volker Rasche, Vinzenz Hombach	11
14	C-Peptide in the Vessel Wall 2009 ·The Review of Diabetic Studies ·Daniel Walcher, Nikolaus Marx	13
15	Signalling processes involved in C-peptide-induced chemotaxis of CD4-positive lymphocytes 2009 ·Cellular and Molecular Life Sciences ·(unknown), Daniel Walcher, Klaudia Giehl, Helga Bach, (unknown), Ronen Durst, Vinzenz Hombach, Nikolaus Marx	12
16	Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population 2009 ·BMC Gastroenterology ·Thomas Walcher, Mark Martin Haenle, Martina Kron, Birgit Hay, Richard Mason, Daniel Walcher, Gerald Steinbach, Peter Kern, Isolde Piechotowski, Guido Adler, Bernhard O. Boehm, Wolfgang Köenig, Wolfgang Kratzer, (unknown)	29
17	C‐Peptide and Atherogenesis: C‐Peptide as a Mediator of Lesion Development in Patients with Type 2 Diabetes Mellitus? 2008 ·Journal of Diabetes Research ·Nikolaus Marx, Daniel Walcher	21
18	Telmisartan Inhibits CD4-Positive Lymphocyte Migration Independent of the Angiotensin Type 1 Receptor via Peroxisome Proliferator-Activated Receptor-γ 2007 ·Hypertension ·Daniel Walcher, Katharina Heß, (unknown), (unknown), (unknown), Ulrich Kintscher, Markus Clemenz, Martin Hartge, (unknown), Vinzenz Hombach, Nikolaus Marx	18
19	Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control 2005 ·Journal of the American College of Cardiology ·Andreas Pfützner, Nikolaus Marx, G Lübben, Matthias Langenfeld, Daniel Walcher, Thomas R. Konrad, Thomas Först	233
20	Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products 2004 ·Diabetes ·Nikolaus Marx, Daniel Walcher, (unknown), (unknown), (unknown), Reinhard Friedl, Vinzenz Hombach, Raffaele De Caterina, Giuseppina Basta, Marie‐Paule Wautier, (unknown)	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact